N/A N=1,839

Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015

Influenza, Human

Bottom Line

View on ClinicalTrials.gov: NCT02885246 ↗

Enrolled (actual)

1,839

Serious AEs

—

Results posted

Mar 2020

Primary outcome: Primary: Number of Seasonal Influenza A and /or B Cases by Age Group, in Panama (Using the Data Reported Via National Influenza Surveillance Program) — 448; 120; 123; 47 Participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: Data collection (Other)
Age: Pediatric, Adult, Older Adult
Sex: All
Sponsor: GlaxoSmithKline
Primary completion: Sep 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Seasonal Influenza A and /or B Cases by Age Group, in Panama (Using the Data Reported Via National Influenza Surveillance Program)	448; 120; 123; 47; 170; 113	—
PRIMARY Number of Seasonal Influenza A Cases by Virus Subtypes, in Panama (Using the Data Reported Via National Influenza Surveillance Program) Among All Influenza Cases A and/or B	259; 189; 80; 43; 119; 51	—
PRIMARY Number of Seasonal Influenza B Cases by Strain Lineage, in Panama (Using the Data Reported Via National Influenza Surveillance Program) Among All Influenza Cases A and/or B	90; 30; 36; 11; 84; 29	—
SECONDARY Number of Cases With Laboratory Confirmed Diagnosis Seasonal Influenza A and/or B Who Experienced Clinical Features (Clinical Symptoms)	41; 4; 0; 2; 40; 4	—
SECONDARY Number of Cases With Laboratory Confirmed Diagnosis Seasonal Influenza A and/or B Who Experienced Outcomes (Complications)	37; 10; 0; 0; 132; 79	—
SECONDARY Number of Seasonal Influenza A and /or B Cases by Southern Hemisphere, Within Different Seasons From 2011 to 2017	41; 0; 93; 172; 177; 0	—
SECONDARY Number of Seasonal Influenza A and /or B Cases by Region, Within Study Period From 2011 to 2017	345; 82; 244; 64; 805; 201	—
SECONDARY Number of Influenza Cases Caused by B- Strain and Presented by B-lineage and by Region Among All Influenza Cases A and/or B	61; 21; 48; 16; 138; 63	—
SECONDARY Number of Circulating Influenza B Lineage Positive Specimens Mismatch With the B-strain Vaccine Recommendation, Among the Number of Influenza B Positive Specimens, by Influenza Seasons	172; 0; 0; 54; 80; 51	—

Summary

The purpose of this study is to assess the prevalence, strain circulation and disease burden of seasonal Influenza A and B in Panama, selected countries of Central America and the Caribbean from the Year 2010 to 2015.

Eligibility Criteria

Inclusion Criteria

All subjects diagnosed with seasonal influenza A and/or B, reported in the ICGES database of Panama, from January 2010 to December 2015.

Exclusion Criteria

N/A.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02885246). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.